Dow Up 1.30% Nasdaq Up 0.37%

Orexigen Therapeutics, Inc. (OREX)

-NasdaqGS
4.13 0.07(1.72%) Oct 30, 4:00PM EDT
Prev Close:4.06
Open:4.00
Bid:4.00 x 500
Ask:5.80 x 600
1y Target Est:11.00
Beta:3.03
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:3.95 - 4.20
52wk Range:3.11 - 7.82
Volume:1,951,363
Avg Vol (3m):4,153,940
Market Cap:506.07M
P/E (ttm):N/A
EPS (ttm):-0.84
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for OREX

Comparison

Symbol% ChgMkt Cap
OREXUp 1.72%506.07M
ABT65.40B
GSK108.52B
RHHBY252.63B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):145.12
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.30
Quarterly EPS Est (Sep-14) :-0.03
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):-0.93

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback